Literature DB >> 9001721

Distribution of phosphoneuroprotein 14 (PNP 14) in vertebrates: its levels as determined by enzyme immunoassay.

S Nakajo1, K Tsukada, H Kameyama, Y Furuyama, K Nakaya.   

Abstract

We have established an enzyme immunoassay for phosphoneuroprotein 14 (PNP 14) which is mainly localized in the cytoplasmic matrix in presynaptic axon terminals and which is phosphorylated in vivo, as well as in vitro. Fab' prepared from rabbit IgG antibodies against bovine PNP 14 was conjugated with maleimide-horseradish peroxidase. The enzyme-conjugated Fab' was used as a second antibody in a sandwich enzyme immunoassay. This assay was able accurately to quantify 0.5-100 ng of rat PNP 14, as well as bovine PNP 14, and it was used for the determination of concentrations of PNP 14 in various rat tissues, neuroblastoma cells, and brains of other vertebrates. The concentrations of PNP 14 in the rat cerebrum, cerebellum, and testis were 1.1, 1.0, and 0.28 micrograms/mg of protein, respectively, and those in other tissues examined were less than 0.1 microgram/mg of protein. PNP 14 was also found in cultured cells, such as rat pheochromocytoma PC12 cells, NG108-15 cells, which are a hybrid between a mouse neuroblastoma and a rat glioma, mouse neuroblastoma Neuro-2a cells, and human neuroblastoma IMR32 cells. Furthermore, PNP 14-specific immunoreactivity was evaluated in the brains of various vertebrates, such as fish, frog, snake and chicken by immunoblot and enzyme immunoassay. The results revealed the immunoreactivity in the brains of all vertebrates examined and the levels were determined to be 0.6-2.1 micrograms bovine PNP 14 equivalents per mg of protein, suggesting that PNP 14 might be an essential component of the central nervous systems of vertebrates.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9001721     DOI: 10.1016/s0006-8993(96)00914-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

Review 1.  Amyloidogenesis of natively unfolded proteins.

Authors:  Vladimir N Uversky
Journal:  Curr Alzheimer Res       Date:  2008-06       Impact factor: 3.498

Review 2.  Alpha-synuclein and presynaptic function: implications for Parkinson's disease.

Authors:  Simon Lykkebo; Poul Henning Jensen
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

3.  Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.

Authors:  M Baba; S Nakajo; P H Tu; T Tomita; K Nakaya; V M Lee; J Q Trojanowski; T Iwatsubo
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

4.  Synucleins Have Multiple Effects on Presynaptic Architecture.

Authors:  Karina J Vargas; Nikolas Schrod; Taylor Davis; Ruben Fernandez-Busnadiego; Yumiko V Taguchi; Ulrike Laugks; Vladan Lucic; Sreeganga S Chandra
Journal:  Cell Rep       Date:  2017-01-03       Impact factor: 9.423

5.  Monomeric synucleins generate membrane curvature.

Authors:  Christopher H Westphal; Sreeganga S Chandra
Journal:  J Biol Chem       Date:  2012-11-26       Impact factor: 5.157

6.  {alpha}-synuclein and its A30P mutant affect actin cytoskeletal structure and dynamics.

Authors:  Vítor L Sousa; Serena Bellani; Maila Giannandrea; Malikmohamed Yousuf; Flavia Valtorta; Jacopo Meldolesi; Evelina Chieregatti
Journal:  Mol Biol Cell       Date:  2009-06-24       Impact factor: 4.138

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.